Boston Scientific launches Latitude analysis program

Interventional device developer Boston Scientific has launched a new clinical science initiative, Altitude, to analyze data from its Latitude Patient Management remote cardiac device monitoring system, the company reported.

Altitude will use Latitude data to answer questions related to implantable cardiac defibrillator and cardiac resynchronization therapy defibrillator device therapy.

Boston Scientific has enrolled 100,000 patients in the Latitude system since its launch in 2006, the Natick, MA-based company said.

Related Reading

Canadian court dismisses J&J lawsuit against Boston Scientific, May 9, 2008

Boston Scientific completes enrollment in MADIT-CRT trial, April 24, 2008

Boston Scientific earns Canadian approval for Taxus, April 17, 2008

Boston Scientific to buy CryoCor, April 16, 2008

Boston Scientific inks deal with Surgi-Vision, April 15, 2008

Page 1 of 603
Next Page